Recent Articles from Business Wire

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or the “Company”) (NASDAQ:BRCB) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against AECOM (“AECOM” or the “Company”) (NYSE:ACM). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Armstrong World Industries, Inc. (“Armstrong World” or the “Company”) (NYSE:AWI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of The Marzetti Company (“Marzetti” or the “Company”) (NASDAQ:MZTI) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.

KBRA assigns preliminary ratings to 10 classes of mortgage pass-through notes from J.P. Morgan Mortgage Trust 2026-4MPR (JPMMT 2026-4MPR). The pool comprises 248 first-lien, fixed rate residential mortgage loans with an aggregate principal balance of $333.5 million as of the cut-off date. The pool includes both non-agency (93.9%) and agency-eligible (6.1%) loans. The weighted average original credit score is 760, which is well within the prime mortgage range.

Lightmatter, the leader in photonic (super)computing, today announced Guide® DR, a high-density laser in an innovative Laser Network Interface Card (“LNIC”) form factor built to OCP NIC 3.0 dimensions. The Guide DR LNIC is a modular, high-density laser array that enables approximately four times the rack density of conventional External Laser Small Form Factor Pluggables (ELSFPs). By relocating the light source from the faceplate into the chassis, the Guide DR LNIC solves the faceplate scaling bottleneck while leveraging existing liquid cooling infrastructure. Guide DR was specifically designed to support Passage® L20 and other high-bandwidth optical interconnects. This provides AI factories the integration flexibility and performance required to drive scale-up clusters to one thousand XPUs and beyond.

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced changes to its senior leadership team aimed at strengthening operational performance and efficiency. As part of these changes, the Board has made the decision that Josh Smiley, President and COO, will no longer be with the Company, effective Friday, May 22.

KBRA assigns a long-term AA- rating to Miami-Dade County (the County), Florida, Aviation Revenue Refunding Bonds, Series 2026A (AMT) and Aviation Revenue Refunding Bonds Series 2026B (Non-AMT) issued for Miami International Airport (MIA). Concurrently, KBRA affirms the AA- rating on the County's approximately $5.1 billion Aviation Revenue Bonds outstanding. The Outlook remains Positive.

Veracyte, Inc. (NASDAQ: VCYT), a leading cancer diagnostics company, announced today that data from two significant phase III clinical trials using its Prosigna Breast and Decipher Prostate tests will be presented at the 2026 ASCO Annual Meeting in Chicago, taking place May 29 – June 2. The OPTIMA and ENZAMET trial presentations are expected to provide practice-changing evidence demonstrating how Veracyte’s genomic tests can guide treatment decisions in both early-stage breast cancer and metastatic prostate cancer.

Conduent Incorporated (Nasdaq: CNDT), a global technology‑driven business solutions and services provider, today announced that it has entered into a definitive agreement to sell its Public Transit business, an operating unit of Conduent Transportation, to Modaxo, a global technology organization focused on moving the world’s people. The Public Transit business consists of Transit Fare Management and Fleet Management Solutions businesses.

Halliburton Company (NYSE: HAL) announced today that its board of directors has declared a 2026 second quarter dividend of seventeen cents ($0.17) a share on the Company’s common stock payable on June 24, 2026, to shareholders of record at the close of business on June 3, 2026.

MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today that it will release the results of the MSCI 2026 Global Market Accessibility Review on June 18, 2026, and the results of the MSCI 2026 Annual Market Classification Review on June 23, 2026.

Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a Gerber Collision property for $3.5 million. The property is located in a highly trafficked corridor in North Carolina and corporate-operated under a triple net lease with approximately eight years of term remaining. The transaction was priced at a 7.5% cap rate on rent as of the closing date including rent credits received at closing and exclusive of transaction costs.

If you have suffered a loss on your New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ:NUAI) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

As organizations race to capture the benefits of artificial intelligence, research from FranklinCovey Institute reveals a critical obstacle: most employees feel they are navigating AI alone, without meaningful support or guidance. Eighty percent of individual contributors describe their manager’s approach to AI as “hands-off,” which underscores a widening gap between AI’s potential and how it’s actually used at work.

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that it filed its Annual Report on Form 10-K for Fiscal Year 2026, which ended March 31, 2026, with the U.S. Securities and Exchange Commission. It is available on Logitech's website at http://ir.logitech.com.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a landmark oncology data program for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will take place May 29–June 2 in Chicago, IL.

Aulos Bioscience, a clinical-stage immuno-oncology company developing an immune-activating antibody therapeutic designed by leveraging an AI platform, today announced positive Phase 2 data from its ongoing Phase 1/2 study of imneskibart in patients with doublet checkpoint inhibitor (CPI)-refractory metastatic melanoma. The data will be presented in a poster session at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting in Chicago, Illinois.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that its full abstract has been released on the ASCO 2026 website. The abstract will be presented within the Head and Neck Cancer Track of the American Society of Clinical Oncology (ASCO) Rapid Oral Abstract Session on June 1, 2026, from 4:30pm to 6:00pm (CDT) in Hall D1 of McCormick Place, Chicago.

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data from its oncology portfolio and pipeline at the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting to be held May 29 – June 2 in Chicago, Illinois. Across more than 60 disclosures and 19 oral presentations, the Company will highlight progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies.

Agendia®, Inc., a leader in precision oncology for breast cancer, today announced new data to be presented at the 2026 American Society of Clinical Oncology (ASCO®) Annual Meeting, taking place May 29 – June 2 in Chicago. The company will present two posters highlighting how MammaPrint® (MP) + BluePrint® (BP) provide biological insights into treatment response and help further refine therapeutic decision-making for patients with early-stage breast cancer (EBC).

Obsidian Therapeutics, Inc., a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies, today announced positive Phase 2 results in patients with advanced melanoma from the Phase 1/2 Agni-01 multicenter study of OBX-115. These data will be presented in an oral presentation by Allison S. Betof, M.D., Ph.D., FASCO, associate professor of medicine (oncology), Stanford School of Medicine, on Monday, June 1, 2026, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL.

Dell Technologies (NYSE: DELL) announces that Arthur Lewis, president of Infrastructure Solutions Group, will present in a fireside chat at the following conference:

858 Therapeutics, a clinical-stage biotechnology company, today announced preliminary safety and efficacy data from its ongoing, first-in-human Phase 1/2 trial of PARG inhibitor ETX-19477. These data will be presented in a poster session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting on Saturday, May 30.

Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced the presentation of initial data from the randomized Phase 2 trial (Duravelo-2) evaluating zelenectide pevedotin (zelenectide) in previously untreated patients with metastatic urothelial cancer (mUC), demonstrating encouraging response rates and a potentially differentiated safety profile both as a monotherapy and in combination with pembrolizumab. In addition, updated data from the Phase 1 trial (Duravelo-1) in previously untreated, cisplatin-ineligible mUC patients demonstrated encouraging median progression-free survival (PFS) comparable to published data for standard of care (SOC). The data announced today will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2 in Chicago.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the first disclosure of Phase 2 data from the C-800-23 study evaluating botensilimab (BOT), Agenus’ multifunctional Fc-enhanced anti-CTLA-4 antibody, with balstilimab (BAL), an anti-PD-1 antibody, in patients with advanced cutaneous melanoma refractory or resistant to prior anti-PD-(L)1 therapy, including patients previously treated with anti-CTLA-4 therapy. The full dataset will be presented by Dr. Michael Atkins on May 31, 2026 at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Genmab A/S (Nasdaq: GMAB) announced today that 23 abstracts, including 20 abstracts evaluating epcoritamab, a subcutaneous T-cell engaging bispecific antibody, will be presented or published at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL, from May 29-June 2, and at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden, from June 11-14.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that together with Kite, a Gilead company, it will present more than 25 abstracts, including six oral presentations, at the 2026 ASCO Annual Meeting (May 29 – June 2) and the 2026 EHA Congress (June 11 – 14). These presentations underscore the increasing diversity of Gilead’s oncology portfolio and pipeline reflecting a growing body of evidence across both solid tumors and hematologic malignancies. Collectively, the data demonstrate Gilead and Kite’s leadership in antibody-drug conjugates (ADCs) and CAR T-cell therapy.

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present multiple abstracts at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, May 29–June 2, 2026, in Chicago.

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage immunotherapy company developing first-in-class logic-gated therapies for solid tumors, today announced the presentation of safety and efficacy data from the ongoing EVEREST-2 clinical study (NCT06051695). The findings, which are being presented in poster presentations during the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place May 29 – June 2, 2026, in Chicago, include updates on the first reported complete response (CR) in a patient with non-small cell lung cancer (NSCLC) following treatment with A2B694, a logic-gated mesothelin (MSLN)-targeted TmodTM chimeric antigen receptor T-cell (CAR T-cell) therapy.

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha radiopharmaceuticals for cancer, today announced the abstract release for its oral presentation on June 1, at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting. The abstract describes interim results from Part 3 of the CONVERGE-01 Phase 2 trial of Ac-225 rosopatamab tetraxetan (CONV01-α) in patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously received Lu-177-PSMA radioligand therapy (Lu-PSMA).

Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present new findings at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, where the cancer center will showcase 49 abstracts spanning solid tumors and blood cancers.

Flatiron Health today announced its presence at the American Society of Clinical Oncology (ASCO) Annual Meeting happening from May 29 - June 2, 2026, in Chicago, Illinois. Flatiron's high-quality real-world data and innovative research capabilities are featured across 25+ research acceptances, including 14 Flatiron-authored poster presentations and online publications.

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has received approval from the KRX to proceed with its Initial Public Offering (IPO). The move marks a pivotal transition for the company, supported by a robust pipeline that includes two clinical-stage assets, one of which is IGT-427 (now called MK-8748), an investigational bi-specific antibody (Anti-VEGF/TIE2), for patients with retinal diseases being developed by Merck (known as MSD outside of the US and Canada).

Exelixis, Inc. (Nasdaq: EXEL) today announced presentations for its flagship product, CABOMETYX® (cabozantinib), and its investigational oral kinase inhibitor, zanzalintinib, at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held from May 29 – June 2 in Chicago.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new retrospective data showing that Noetik’s artificial intelligence-based TARIO-2 model identified spatial tumor microenvironment patterns associated with clinical outcomes from routine pretreatment tumor pathology images in patients treated with botensilimab (BOT) plus balstilimab (BAL), Agenus’ investigational next-generation multifunctional, Fc-enhanced anti-CTLA-4 and anti-PD-1 immunotherapy combination.

Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Veritone, Inc. (NASDAQ: VERI) securities between October 14, 2025 and April 14, 2026. Veritone engages in the provision of artificial intelligence (“AI”) computing solutions and services.

Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Pinterest, Inc. (NYSE: PINS) between February 7, 2025 and February 12, 2026. Pinterest describes itself as a “a visual social media platform on which users organize various kinds of content into “boards”, which serve as inspiration for projects the user hopes to complete.”

Daytona International Speedway today announced a transformative, venue-wide LED lighting project that will introduce the next generation of lighting technology to the “World Center of Racing,” marking the next step in how motorsports are experienced by fans, competitors and viewers around the world.

Mayville Engineering Company (NYSE: MEC) (the “Company” or “MEC”), a leading value-added provider of design, prototyping and manufacturing solutions serving diverse end markets, today announced the closing of its underwritten public offering of 5,000,000 shares of its common stock at a public offering price of $20.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and other offering expenses payable by MEC. This amount includes the exercise in full by the underwriters of their option to purchase up to an additional 652,000 shares of common stock in the offering (the “Option”).

Morgan Stanley (NYSE: MS) today announced the winners of its 17th annual Strategy Challenge, the Firm’s flagship pro bono program which brings together rising talent to help nonprofits solve strategic, mission-critical challenges. The winning teams supported Hour Children in the U.S. and Mental Health Innovations in the UK.

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights of its 2026 Invisalign® EMEA Ortho Summit, which brought together approximately 400 orthodontists and dental professionals from across Europe, the Middle East, and Africa (EMEA).

Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”) announces the successful bolt-on acquisition of 5,154 net undeveloped acres in the core of the Delaware Basin as part of the Bureau of Land Management (BLM) Oil and Gas Lease Sale this week.

Glancy Prongay Wolke & Rotter LLP (“GPWR”), announces that it has filed a class action lawsuit in the United States District Court for the Central District of California, captioned Elwan v. Veritone, Inc., et al., Case No. 8:26-cv-01275, on behalf of persons and entities that purchased or otherwise acquired Veritone, Inc. (“Veritone” or the “Company”) (NASDAQ: VERI) securities between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

All Remote — GitLab Inc., the intelligent orchestration platform for DevSecOps, today released GitLab 19.0, expanding secrets management, agentic merge request workflows, CI pipeline visibility, self-hosted open source model support, and supply chain visibility.

Falcon’s Beyond Global, Inc. (Nasdaq: FBYD) (“Falcon’s Beyond”, “Falcon’s”, or the “Company”), a visionary entertainment and technology enterprise at the forefront of the global experience economy, today announced that the Company’s 11% Series B Cumulative Convertible Preferred Stock began trading on the Nasdaq Global Market under the symbol “FBYDP”, effective as of market open on May 21, 2026.

Radian Group Inc. (NYSE: RDN) today announced that Chief Executive Officer Rick Thornberry has informed the Board of Directors of his intent to retire in December 2026, following nearly a decade of leadership that fundamentally transformed the company.

Hyatt Hotels Corporation (NYSE: H) announced today participation by executives at the following conferences:

Cencora, Inc. (NYSE: COR) today updated its fiscal year 2026 financial guidance as a result of recent opportunistic share repurchases. Cencora now expects adjusted diluted earnings per share to be in the range of $17.70 to $17.90, up from the previous range of $17.65 to $17.90. The opportunistic share repurchases completed in May align with the Company’s previously disclosed expectation that it will repurchase $1.0 billion in shares of common stock by the end of calendar 2026.

UiPath (NYSE: PATH), a global leader in business orchestration and automation, today announced it has been named a Leader in The Forrester Wave™: Document Mining and Analytics Platforms, Q2 2026, reinforcing the company’s position among top vendors in document mining and analytics. With its UiPath IXP (Intelligent Xtraction and Processing) solution, part of the UiPath Platform, UiPath is helping to define the category and empower enterprises to use business orchestration and agents to extract, interpret, and process information from a wide range of document types, enabling reliable automation of document-intensive workflows at enterprise scale.

Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Stifel Jaws & Paws Conference.

Standard Insurance Company (The Standard) and Pacific Guardian Life announced today a definitive agreement under which The Standard will transition its individual annuities business to Pacific Guardian Life. The Standard and Pacific Guardian Life are both members of the global Meiji Yasuda Life Insurance Company family. The transaction is expected to close in early 2027, subject to regulatory approvals and other customary closing conditions.

Liberty Capital Corporation (“Liberty Capital”) (Nasdaq: GLIBA, GLIBK) announced today that the company completed its name change from GCI Liberty, Inc., effective at the close of business today. The company’s stock tickers will remain unchanged. Liberty Capital’s Alaska subsidiary will continue to operate under the GCI name and brand.

Elastic (NYSE: ESTC), the Search AI Company, announced that its management will present at the following conferences:

Exit Partners, a boutique investment banking and M&A advisory firm specializing in founder-led businesses, today announced that it served as the exclusive sell-side advisor to Casa de Perrin in its strategic sale to Curated Events.

Trinity Industries, Inc. (NYSE:TRN) has declared a quarterly dividend of 31 cents per share on its $0.01 par value common stock. The quarterly cash dividend, representing Trinity’s 249th consecutively paid dividend, is payable July 31, 2026 to stockholders of record on July 15, 2026.

Neptune Insurance Holdings, Inc. (“Neptune”) (NYSE: NP), the largest private flood insurance provider in the United States, today announced the nationwide launch of Atlas+, Neptune’s new AI-powered platform experience for insurance agents.

Guidewire (NYSE: GWRE) announced that it will release its financial results for the fiscal quarter ended April 30, 2026 after market close on Thursday, June 4, 2026. On that day, management will host an audio webcast at 2:00 p.m. PT (5:00 p.m. ET) to review and discuss the Company’s results for the third quarter fiscal year 2026. The live audio webcast will be accessible to the public through the Investor Relations website at https://ir.guidewire.com/. A replay of the webcast will be available two hours after the conclusion of the live event and archived for a period of three months.

Copart, Inc. (NASDAQ: CPRT) today reported financial results for the quarter ended April 30, 2026.

Universal Corporation (NYSE:UVV), a global business-to-business agriproducts company, will webcast its conference call at 10:00 a.m. Eastern Time on May 29, 2026. The Company will release its results for fiscal year 2026 after market close on May 28, 2026.

Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that Matthew Gourmand, President of Omega, will become the Company’s Chief Executive Officer in conjunction with the planned retirement of Taylor Pickett effective October 1, 2026. Mr. Pickett will step down from the Board of Directors upon his retirement, and the Board of Directors intends to appoint Mr. Gourmand to the Board, effective on that date.

Assurant, Inc. (NYSE: AIZ), a global company that redefines the boundaries of protection – safeguarding and servicing connected devices, homes, automobiles, and commercial equipment in partnership with the world’s most successful brands, announced today that its Board of Directors declared a quarterly dividend of $0.88 per share of common stock. The dividend will be payable on June 29, 2026 to stockholders of record as of the close of business on June 8, 2026.

Radian Group Inc. (NYSE: RDN) announced today that its stockholders re-elected all eleven of the company’s director nominees, who serve one-year terms and are elected annually. As previously disclosed, Gregory Serio, a director of the company since 2012, retired at the end of his current term following today’s 2026 Annual Meeting. Serio’s retirement comes after a successful tenure during which Radian transformed into a global multi-line specialty insurer.

TechnipFMC (NYSE: FTI) announced today that Doug Pferdehirt, Chair and Chief Executive Officer, will speak at the Bernstein 42nd Annual Strategic Decisions Conference on Wednesday, May 27, 2026, at 9:00 a.m. ET in New York, NY.

Tanger® (NYSE: SKT), a leading owner and operator of outlet and other open-air retail shopping destinations, has released its 2025 Impact Report for the annual period ending December 31, 2025, marking a decade of reporting on the company’s sustainability and corporate responsibility initiatives. Also today, the Institute for Market Transformation announced that Tanger has been named a 2026 Green Lease Leader at the Silver level.

MFS Investment Management (“MFS”) announced today that the reorganization of MFS High Income Municipal Trust (NYSE: CXE), MFS High Yield Municipal Trust (NYSE: CMU), and MFS Investment Grade Municipal Trust (NYSE: CXH) (each a “Target Fund” and collectively, the “Target Funds”) into MFS Municipal Income Trust (NYSE: MFM) (the “Surviving Fund”) (each a “Reorganization” and collectively, the “Reorganizations”) will be completed by the open of business on the New York Stock Exchange (“NYSE”) on Monday, June 8, 2026, subject to the satisfaction of certain closing conditions.

JPMorgan Chase Financial Company LLC announced today the quarterly coupon amount for the Alerian MLP Index ETN (NYSE Arca: AMJB). The table below summarizes the coupon amount for the Alerian MLP Index ETN due January 28, 2044 (the “Notes”).

American Tower Corporation (NYSE: AMT) announced that its Board of Directors has declared a quarterly cash distribution of $1.79 per share on shares of the Company’s common stock. The distribution is payable on July 13, 2026 to the stockholders of record at the close of business on June 12, 2026.

Red River, a technology transformation company specializing in AI-driven cybersecurity and IT infrastructure solutions for government and enterprise customers, today announced the appointment of Mike Sang as Chief Financial Officer. In this role, Sang will lead Red River’s finance organization and oversee financial strategy, planning, reporting and operations in support of the company’s continued growth.

On May 21, 2026, the Board of Trustees of BNY Mellon High Yield Strategies Fund (NYSE: DHF) declared from net investment income a monthly cash dividend of $0.0175 per share of beneficial interest, payable on June 22, 2026, to shareholders of record at the close of business on June 5, 2026. The ex-dividend date is June 5, 2026. The previous dividend declared in April was $0.0175 per share of beneficial interest.

Upstart Holdings, Inc. (NASDAQ: UPST), the leading artificial intelligence (AI) lending marketplace, today announced that Paul Gu, Co-founder and CEO, will participate in a fireside chat at the Morgan Stanley US Financials Conference on Wednesday, June 10, at 3:15 pm ET (12:15 pm PT).

On March 23, 2026, The Estée Lauder Companies Inc. (NYSE: EL) and Puig confirmed they were in discussions regarding a potential business combination, but unless and until an agreement was signed between the companies, there could be no assurances regarding the deal or its terms.

The Toro Company (NYSE: TTC), a leading global provider of solutions for the outdoor environment, today announced that it will release its fiscal 2026 second quarter results on Thursday, June 4, at approximately 7:30 a.m. CT. The full text of The Toro Company’s earnings release will be available at that time at www.thetorocompany.com/invest. The company will also hold an earnings conference call at 10 a.m. CT that day.

Palmer Square Capital BDC Inc. (NYSE: PSBD) (“PSBD” or the “Company”), an externally managed business development company, today announced that the Company’s board of directors authorized an increase and extension of the Company’s previously established open-market share repurchase program (the “Repurchase Program”).

Argan, Inc. (NYSE: AGX) (“Argan” or the “Company”) today announced that the Company will release its first quarter fiscal 2027 financial results after the market closes on Thursday, June 4, 2026.